|1|Human Organic Cation Transporter 1 Protein Levels of Granulocytes Can Optimize Imatinib Therapy in Patients with Chronic Myeloid Leukemia. (25358338)
Cao C.... Zhu H.
|2|Gambogic Acid Induces Apoptosis in Imatinib-Resistant Chronic Myeloid Leukemia Cells via Inducing Proteasome Inhibition and Caspase-Dependent Bcr-Abl Downregulation. (24334603)
Shi X.... Liu J.
|3|Intraventricular hemorrhage in a patient with chronic myeloid leukemia and anterior communicating artery aneurysm. (23860156)
Aggarwal A.... Futane S.
|4|Treatment-, patient-, and disease-related factors and the emergence of adverse events with tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia. (23553655)
Irvine E.... Williams C.
|5|Sudden extramedullary blast crisis of chronic myeloid leukemia manifesting as T-cell lymphoblastic lymphoma. (23486000)
Wei J.... Zhou J.
|6|Dasatinib: a guide to its use in chronic myeloid leukemia in the EU. (23549840)
Keating G.M.... Keam S.J.
|7|Apoptosis Induced by Tanshinone IIA and Cryptotanshinone Is Mediated by Distinct JAK/STAT3/5 and SHP1/2 Signaling in Chronic Myeloid Leukemia K562 Cells. (23878608)
Jung J.H.... Kim S.H.
|8|p-Stat3 and bcr/abl gene expression in chronic myeloid leukemia and their relation to imatinib therapy. (24374144)
Sayed D.... Khalaf M.R.
|9|ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia. (23275297)
Jiang Q.... Jamieson C.H.
|10|Bone metabolism, growth rate and pubertal development in children with chronic myeloid leukemia treated with imatinib during puberty. (22983586)
Giona F.... FoA R.
|11|Successful rechallenge with imatinib in a patient with chronic myeloid leukemia who previously experienced imatinib mesylate induced pneumonitis. (24416057)
Go S.W.... Kang J.Y.
|12|Chronic phase chronic myeloid leukemia patients with low OCT-1 activity randomized to high-dose imatinib achieve better responses and have lower failure rates than those randomized to standard-dose imatinib. (22207690)
White D.L.... Hughes T.P.
|13|Targeting of GSK3I^ promotes imatinib-mediated apoptosis in quiescent CD34+ chronic myeloid leukemia progenitors, preserving normal stem cells. (22262776)
Reddiconto G.... Coluccia A.M.
|14|Chronic myeloid leukemia with extreme thrombocytosis. (22479272)
Kim S.Y.... Park T.S.
|15|Primary cutaneous anaplastic large-cell lymphoma occurring in a case of chronic myeloid leukemia in remission. (22775801)
Charafeddine K.M.... Khalifeh I.
|16|Low-level Bcr-Abl mutations are very rare in chronic myeloid leukemia patients who are in major molecular response on first-line nilotinib. (21762985)
Soverini S.... Martinelli G.
|17|Summary of 615 patients of chronic myeloid leukemia in Shanghai from 2001 to 2006. (20199658)
Wang A.H.... Li J.M.
|18|RAD 001 (everolimus) prevents mTOR and Akt late re-activation in response to imatinib in chronic myeloid leukemia. (20014066)
Mancini M.... Santucci M.A.
|19|Analysis of CYP3A5*3 and CYP3A5*6 gene polymorphisms in Indian chronic myeloid leukemia patients. (21039054)
Sailaja K.... Vishnupriya S.
|20|Bcr/Abl interferes with the Fanconi anemia/BRCA pathway: implications in the chromosomal instability of chronic myeloid leukemia cells. (21203397)
Valeri A.... Bueren J.A.
|21|Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression. (19420358)
Mumprecht S.... Ochsenbein A.F.
|22|Sphingosine kinase-1 is a downstream regulator of imatinib-induced apoptosis in chronic myeloid leukemia cells. (18401414)
Bonhoure E.... Cuvillier O.
|23|Isolated thrombocytosis as first sign of chronic myeloid leukemia with e6a2 BCR/ABL fusion transcript, JAK2 negativity and complete response to imatinib. (17688946)
Breccia M.... Alimena G.
|24|Transient potent BCR-ABL inhibition is sufficient to commit chronic myeloid leukemia cells irreversibly to apoptosis. (19061839)
Shah N.P.... Sawyers C.L.
|25|Philadelphia chromosome-positive chronic myeloid leukemia with p190(BCR-ABL) rearrangement, overexpression of the EVI1 gene, and extreme thrombocytosis: a case report. (18262061)
Balatzenko G.... Toshkov S.
|26|Induction of G2/M phase arrest and apoptosis by a novel enediyne derivative, THDB, in chronic myeloid leukemia (HL-60) cells. (17064874)
Lu Y.J.... Lin S.R.
|27|Efficacy and safety of imatinib in patients with chronic myeloid leukemia and complete or near-complete cytogenetic response to interferon-alpha. (17607681)
Branford S.... Taylor K.
|28|Immunotherapeutic strategies in chronic myeloid leukemia. (20425356)
|29|Adenomatoid tumor of the testis in a patient on imatinib therapy for chronic myeloid leukemia. (16923575)
Piccin A.... McCann S.
|30|Chronic myeloid leukemia: current application of cytogenetics and molecular testing for diagnosis and treatment. (15757021)
Tefferi A.... Kantarjian H.M.
|31|Factors predicting molecular and cytogenetic response in chronic myeloid leukemia patients treated with imatinib. (15642682)
Roche-Lestienne C.... Preudhomme C.
|32|Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides. (15626746)
Aichberger K.J.... Sillaber C.
|33|Molecular and cytogenetic characterization of a novel translocation t(4;22) involving the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with atypical chronic myeloid leukemia. (15034867)
Safley A.M.... Goodman B.K.
|34|Clonal cytogenetic abnormalities in Philadelphia chromosome negative cells in chronic myeloid leukemia patients treated with imatinib. (15512807)
Loriaux M.... Deininger M.
|35|Interferon-alpha, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia. (12393722)
Burchert A.... Neubauer A.
|36|Granulocyte colony-stimulating factor reverses cytopenia and may permit cytogenetic responses in patients with chronic myeloid leukemia treated with imatinib mesylate. (12604417)
Marin D.... Apperley J.F.
|37|Analysis of cytogenetic response in Ph+ chronic myeloid leukemia patients treated with interferon alpha]. (12844411)
Hong H.... Lu D.P.
|38|Usefulness of quantitative assessment of Wilms tumor suppressor gene expression in chronic myeloid leukemia patients undergoing imatinib therapy. (12783374)
Cilloni D.... Saglio G.
|39|Treatment of chronic myeloid leukemia with autologous transplantation using peripheral blood stem cells or bone marrow cultured in IL-2 followed by IL-2, GM-CSF, and IFN-alpha administration. (12665687)
HA!jek R.... VorlA-cek J.
|40|Drug therapy of chronic myeloid leukemia]. (11831070)
Hochhaus A.... Hehlmann R.
|41|Cytokine expression of T cells in chronic myeloid leukemia. (11775253)
Liu Y.... Andreeff M.
|42|Quantitative evaluation of BCR-ABL amount of transcript post mobilization with G-CSF of peripheral blood stem cells from chronic myeloid leukemia patients in cytogenetic response. (10975389)
Martinelli G.... Tura S.
|43|3' BCR recombines with IGL locus in BCR-ABL-positive philadelphia-negative chronic myeloid leukemia. (10534772)
Benjes S.M.... Morris C.M.
|44|Absence of influence of prior treatment with interferon on the outcome of allogeneic bone marrow transplantation for chronic myeloid leukemia. (9678795)
TomA!s J.F.... FernA!ndez-RaA+ada J.M.
|45|Lineage involvement of stem cells bearing the philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence-activated cell sorting and fluorescence in situ hybridization. (9845542)
Takahashi N.... Miura A.B.
|46|Fluorescence in situ hybridization (FISH) on peripheral blood smears for monitoring Philadelphia chromosome-positive chronic myeloid leukemia (CML) during interferon treatment: a new strategy for remission assessment. (9491319)
MA1hlmann J.... Duba H.C.
|47|P53, p15INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia. (10069444)
GA1ran S.... YalAsin A.
|48|The role of DNA damage in the resistance of human chronic myeloid leukemia cells to cyclophosphamide analogues. (7923171)
Andersson B.S.... Murray D.
|49|Management of chronic myeloid leukemia in chronic phase with autologous stem cell transplantation and alpha-2 interferon: cytogenetic and clinical results. (7902746)
Alimena G.... Cedrone M.
|50|"Coexistent chronic myeloid leukemia and lymphosarcoma in the maxilla: report of a case". (6594459)
Epivatianos A.A.... Trigonidis G.